323 related articles for article (PubMed ID: 33986753)
21. Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia.
Yang F; Wang R; Feng W; Chen C; Yang X; Wang L; Hu Y; Ren Q; Zheng G
Mol Immunol; 2018 Jan; 93():68-78. PubMed ID: 29154208
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine.
Tsirogianni M; Grigoriou E; Kapsimalli V; Dagla K; Stamouli M; Gkirkas K; Konsta E; Karagiannidou A; Gkodopoulos K; Stavroulaki G; Pappa V; Angelopoulou M; Lowdell M; Tsirigotis P
Leuk Lymphoma; 2019 Oct; 60(10):2457-2463. PubMed ID: 30947589
[TBL] [Abstract][Full Text] [Related]
23. Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.
Hua Y; Wang C; Jiang H; Wang Y; Liu C; Li L; Liu H; Shao Z; Fu R
Int J Hematol; 2017 Aug; 106(2):248-257. PubMed ID: 28405919
[TBL] [Abstract][Full Text] [Related]
24. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
[TBL] [Abstract][Full Text] [Related]
25. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.
Romee R; Rosario M; Berrien-Elliott MM; Wagner JA; Jewell BA; Schappe T; Leong JW; Abdel-Latif S; Schneider SE; Willey S; Neal CC; Yu L; Oh ST; Lee YS; Mulder A; Claas F; Cooper MA; Fehniger TA
Sci Transl Med; 2016 Sep; 8(357):357ra123. PubMed ID: 27655849
[TBL] [Abstract][Full Text] [Related]
26. NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.
Wang Y; Chen C; Dong F; Ma S; Xu J; Gong Y; Cheng H; Zhou Y; Cheng T; Hao S
Sci China Life Sci; 2015 Dec; 58(12):1288-98. PubMed ID: 26588911
[TBL] [Abstract][Full Text] [Related]
27. 161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.
Sarhan D; Brandt L; Felices M; Guldevall K; Lenvik T; Hinderlie P; Curtsinger J; Warlick E; Spellman SR; Blazar BR; Weisdorf DJ; Cooley S; Vallera DA; Önfelt B; Miller JS
Blood Adv; 2018 Jun; 2(12):1459-1469. PubMed ID: 29941459
[TBL] [Abstract][Full Text] [Related]
28. Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission.
Dauguet N; Récher C; Demur C; Fournié JJ; Poupot M; Poupot R
Am J Hematol; 2011 Feb; 86(2):209-13. PubMed ID: 21264910
[TBL] [Abstract][Full Text] [Related]
29. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cell receptor repertoire is comparable amongst newly diagnosed acute myeloid leukemia of different French-American-British subtypes, risk categories and chemosensitivities.
Ho X; Fook-Chong S; Linn YC
Leuk Lymphoma; 2014 Feb; 55(2):342-8. PubMed ID: 23550989
[TBL] [Abstract][Full Text] [Related]
31. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.
Brauneck F; Seubert E; Wellbrock J; Schulze Zur Wiesch J; Duan Y; Magnus T; Bokemeyer C; Koch-Nolte F; Menzel S; Fiedler W
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884723
[TBL] [Abstract][Full Text] [Related]
32. Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia.
Yao D; Xu L; Liu L; Zeng X; Zhong J; Lai J; Zheng R; Jin Z; Chen S; Zha X; Huang X; Lu Y
Biomed Res Int; 2020; 2020():9531549. PubMed ID: 33102599
[TBL] [Abstract][Full Text] [Related]
33. Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT
Zeng X; Yao D; Liu L; Zhang Y; Lai J; Zhong J; Zha X; Lu Y; Jin Z; Chen S; Li Y; Xu L
Asia Pac J Clin Oncol; 2022 Aug; 18(4):456-464. PubMed ID: 34811925
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors.
Vitale C; Pitto A; Benvenuto F; Ponte M; Bellomo R; Frassoni F; Mingari MC; Bacigalupo A; Moretta L
Hematol J; 2000; 1(2):136-44. PubMed ID: 11920181
[TBL] [Abstract][Full Text] [Related]
35. Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome.
Sohlberg E; Pfefferle A; Andersson S; Baumann BC; Hellström-Lindberg E; Malmberg KJ
Oncotarget; 2015 Oct; 6(33):34178-90. PubMed ID: 26497557
[TBL] [Abstract][Full Text] [Related]
36. Natural killer expansion, human leukocyte antigens-E expression and CD14(+) CD56(+) monocytes in a myelodysplastic syndrome patient.
Terrazzano G; Rubino V; Palatucci AT; Giovazzino A; Annunziatella M; Vitagliano O; Alfinito F; Ruggiero G
Eur J Haematol; 2013 Sep; 91(3):265-269. PubMed ID: 23734938
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
Front Immunol; 2018; 9():977. PubMed ID: 29780393
[TBL] [Abstract][Full Text] [Related]
38. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
[TBL] [Abstract][Full Text] [Related]
39. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
40. Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion.
Khaznadar Z; Boissel N; Agaugué S; Henry G; Cheok M; Vignon M; Geromin D; Cayuela JM; Castaigne S; Pautas C; Raffoux E; Lachuer J; Sigaux F; Preudhomme C; Dombret H; Dulphy N; Toubert A
J Immunol; 2015 Sep; 195(6):2580-90. PubMed ID: 26246143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
